Article
Claudin‑9 is a novel prognostic biomarker for endometrial cancer
21 Sept 2022
Abstract excerpt
The tight‑junction protein claudin‑9 (CLDN9) is barely distributed in normal adult tissues but is ectopically expressed in various cancer types. Although multiple databases indicated upregulation of CLDN9 in endometrial cancers at the mRNA level, its protein expression and biological roles remain obscure. In the present study, the prognostic significance of CLDN9 expression in endometrial cancer was evaluated by...
Topics
Join the communities discussing this publication.